Predictive value of vrk 1 and 2 for rectal adenocarcinoma response to neoadjuvant chemoradiation therapy: a retrospective observational cohort study

[1] Bosset JF(2006)Chemotherapy with preoperative radiotherapy in rectal cancer N Engl J Med 355 1114-1123

[2] Collette L(2009)Rectal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up Ann Oncol 20 54-56

[3] Calais G(2015)Predictive and prognostic biomarkers for neoadjuvant chemoradiotherapy in locally advanced rectal cancer Crit Rev Oncol Hematol 96 67-80

[4] Mineur L(2012)Neoadjuvant treatment response as an early response indicator for patients with rectal cancer J Clin Oncol 30 1770-1776

[5] Maingon P(2000)Prognostic significance of postchemoradiation stage following preoperative chemotherapy and radiation for advanced/recurrent rectal cancers Int J Radiat Oncol Biol Phys 48 1075-1080

[6] Radosevic-Jelic L(2011)18Fluoro-deoxy-glucose positron emission tomography in assessing tumor response to preoperative chemoradiation therapy for locally advanced rectal cancer J Surg Oncol 103 17-24

[7] Daban A(2009)Biomarkers for response to neoadjuvant chemoradiation for rectal cancer Int J Radiat Oncol Biol Phys 74 673-688

[8] Bardet E(1992)Vaccinia virus gene B1R encodes a 34-kDa serine/threonine protein kinase that localizes in cytoplasmic factories and is packaged into virions Virology 191 803-812

[9] Beny A(1997)Identification of two novel human putative serine/threonine kinases, VRK1 and VRK2, with structural similarity to vaccinia virus B1R kinase Genomics 45 327-331

[10] Ollier JC(2004)Characterization of three paralogous members of the Mammalian vaccinia related kinase family J Biol Chem 279 7934-7946

[1] Bosset JF(2006)Chemotherapy with preoperative radiotherapy in rectal cancer N Engl J Med 355 1114-1123

[2] Collette L(2009)Rectal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up Ann Oncol 20 54-56

[3] Calais G(2015)Predictive and prognostic biomarkers for neoadjuvant chemoradiotherapy in locally advanced rectal cancer Crit Rev Oncol Hematol 96 67-80

[4] Mineur L(2012)Neoadjuvant treatment response as an early response indicator for patients with rectal cancer J Clin Oncol 30 1770-1776

[5] Maingon P(2000)Prognostic significance of postchemoradiation stage following preoperative chemotherapy and radiation for advanced/recurrent rectal cancers Int J Radiat Oncol Biol Phys 48 1075-1080

[6] Radosevic-Jelic L(2011)18Fluoro-deoxy-glucose positron emission tomography in assessing tumor response to preoperative chemoradiation therapy for locally advanced rectal cancer J Surg Oncol 103 17-24

[7] Daban A(2009)Biomarkers for response to neoadjuvant chemoradiation for rectal cancer Int J Radiat Oncol Biol Phys 74 673-688

[8] Bardet E(1992)Vaccinia virus gene B1R encodes a 34-kDa serine/threonine protein kinase that localizes in cytoplasmic factories and is packaged into virions Virology 191 803-812

[9] Beny A(1997)Identification of two novel human putative serine/threonine kinases, VRK1 and VRK2, with structural similarity to vaccinia virus B1R kinase Genomics 45 327-331

[10] Ollier JC(2004)Characterization of three paralogous members of the Mammalian vaccinia related kinase family J Biol Chem 279 7934-7946